SARASOTA, Fla., March 06, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for concussion and brain-related health conditions ...
Research analysts at StockNews.com initiated coverage on shares of Oragenics (NYSE:OGEN – Get Free Report) in a research note issued on Wednesday. The firm set a “sell” rating on the stock. Oragenics ...
Hosted on MSN7mon
Ogen's new initiative provides lifeline to war-affected israelisIn response to the ongoing conflict with Hamas and Hezbollah, Ogen, a leading nonprofit social lending organization, has introduced a new initiative called "Ogen for the Future" to support ...
Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for concussion and brain-related health conditions, today announced its participation at the Emergencies ...
Oragenics Inc (NASDAQ:OGEN) shares are trading lower by 45.5% to $0.58 during Wednesday’s session after the company announced ...
Oragenics (OGEN) announced the submission of its Investigator’s Brochure application in preparation for its Phase II clinical trial using ...
StockNews.com initiated coverage on shares of Oragenics (NYSE:OGEN – Free Report) in a research note released on Tuesday. The firm issued a sell rating on the stock. Oragenics Stock Performance OGEN ...
SARASOTA, Fla., March 06, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for concussion and brain-related health conditions, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback